For research use only. Not for therapeutic Use.
TJ-M2010-5(Cat No.:I037337)is a humanized monoclonal antibody designed to selectively inhibit interleukin-33 (IL-33), a cytokine involved in allergic inflammation and immune regulation. By targeting IL-33, TJ-M2010-5 blocks its interaction with the ST2 receptor, thereby suppressing downstream signaling pathways that lead to Th2-mediated immune responses. This antibody shows potential in treating inflammatory and allergic diseases such as asthma, atopic dermatitis, and allergic rhinitis. With its high specificity and efficacy in neutralizing IL-33 activity, TJ-M2010-5 is a promising candidate for preclinical and clinical studies focused on immune modulation and chronic inflammation.
CAS Number | 1357471-57-8 |
Synonyms | 3-(4-benzylpiperazin-1-yl)-N-(4-phenyl-1,3-thiazol-2-yl)propanamide |
Molecular Formula | C23H26N4OS |
Purity | ≥95% |
IUPAC Name | 3-(4-benzylpiperazin-1-yl)-N-(4-phenyl-1,3-thiazol-2-yl)propanamide |
InChI | InChI=1S/C23H26N4OS/c28-22(25-23-24-21(18-29-23)20-9-5-2-6-10-20)11-12-26-13-15-27(16-14-26)17-19-7-3-1-4-8-19/h1-10,18H,11-17H2,(H,24,25,28) |
InChIKey | DTIQJBUDKQVBLT-UHFFFAOYSA-N |
SMILES | C1CN(CCN1CCC(=O)NC2=NC(=CS2)C3=CC=CC=C3)CC4=CC=CC=C4 |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |